Cherry SE Calls Extraordinary General Meeting to Address Financial Restructuring
Cherry SE has convened an Extraordinary General Meeting to approve a reverse share split aimed at restoring capital market eligibility while delaying its annual financial report due to audit complexities.
Cherry SE, a global manufacturer of computer input devices and digital healthcare solutions, has convened an Extraordinary General Meeting for May 22, 2026, to address significant financial restructuring needs. The company is evaluating financing options to support further restructuring and growth initiatives, requiring shareholder approval for a reverse share split in a 4:1 ratio intended to offset accumulated balance sheet losses and restore capital market eligibility.
The decision to hold an extraordinary meeting stems from delays in the company's annual reporting timeline. A change of auditor and related first-time audit procedures have extended the completion timeframe, pushing the publication of the annual financial report to July 15, 2026. By convening the Extraordinary General Meeting separately, Cherry SE ensures that the capital restoration process can proceed independently of the revised financial reporting schedule.
This move highlights the company's urgent need to address financial challenges while maintaining operational momentum. Preliminary results for the 2025 fiscal year were published on March 5, 2026, with the full Q1/2025 quarterly financial report scheduled for release on the company's investor relations website from May 7, 2026. Investors can access these documents through the company's investor portal at https://ir.cherry.de/en/.
The implications of this announcement extend beyond immediate financial restructuring. For shareholders, the reverse share split represents a critical step toward stabilizing the company's market position and potentially attracting new investment. The delay in annual reporting, while attributed to audit complexities, raises questions about transparency and timing that could affect investor confidence during a period of significant corporate transition.
Cherry SE's dual focus on computer peripherals and digital healthcare solutions positions it in competitive but growing markets. The financial restructuring comes as the company seeks to execute further initiatives in both sectors, making the restoration of capital market eligibility essential for funding future growth. The extraordinary meeting outcome will likely determine the company's near-term financial flexibility and strategic options.